Erratum to: FCGR3A-158 polymorphism influences the biological response to infliximab in Crohn’s disease through affecting the ADCC activity [Immunogenetics, 65, (2013) 265-271, DOI 10.1007/s00251-013-0679-8]

Rintaro Moroi; Katsuya Endo; Yoshitaka Kinouchi; Hisashi Shiga; Yoichi Kakuta; Masatake Kuroha; Yoshitake Kanazawa; Yosuke Shimodaira; Takahiko Horiuchi; Seiichi Takahashi; Tooru Shimosegawa

doi:10.1007/s00251-015-0861-2

Erratum to: FCGR3A-158 polymorphism influences the biological response to infliximab in Crohn’s disease through affecting the ADCC activity [Immunogenetics, 65, (2013) 265-271, DOI 10.1007/s00251-013-0679-8]

Rintaro Moroi, Katsuya Endo, Yoshitaka Kinouchi, Hisashi Shiga, Yoichi Kakuta, Masatake Kuroha, Yoshitake Kanazawa, Yosuke Shimodaira, Takahiko Horiuchi, Seiichi Takahashi, Tooru Shimosegawa

Internal Medicine

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English
Pages (from-to)	545
Number of pages	1
Journal	Immunogenetics
Volume	67
Issue number	9
DOIs	https://doi.org/10.1007/s00251-015-0861-2
Publication status	Published - Sep 19 2015

All Science Journal Classification (ASJC) codes

Immunology
Genetics

Access to Document

10.1007/s00251-015-0861-2

Cite this

Moroi, R., Endo, K., Kinouchi, Y., Shiga, H., Kakuta, Y., Kuroha, M., Kanazawa, Y., Shimodaira, Y., Horiuchi, T., Takahashi, S., & Shimosegawa, T. (2015). Erratum to: FCGR3A-158 polymorphism influences the biological response to infliximab in Crohn’s disease through affecting the ADCC activity [Immunogenetics, 65, (2013) 265-271, DOI 10.1007/s00251-013-0679-8]. Immunogenetics, 67(9), 545. https://doi.org/10.1007/s00251-015-0861-2

Erratum to : FCGR3A-158 polymorphism influences the biological response to infliximab in Crohn’s disease through affecting the ADCC activity [Immunogenetics, 65, (2013) 265-271, DOI 10.1007/s00251-013-0679-8]. / Moroi, Rintaro; Endo, Katsuya; Kinouchi, Yoshitaka; Shiga, Hisashi; Kakuta, Yoichi; Kuroha, Masatake; Kanazawa, Yoshitake; Shimodaira, Yosuke; Horiuchi, Takahiko; Takahashi, Seiichi; Shimosegawa, Tooru.

In: Immunogenetics, Vol. 67, No. 9, 19.09.2015, p. 545.

Research output: Contribution to journal › Comment/debate › peer-review

Moroi, R, Endo, K, Kinouchi, Y, Shiga, H, Kakuta, Y, Kuroha, M, Kanazawa, Y, Shimodaira, Y, Horiuchi, T, Takahashi, S & Shimosegawa, T 2015, 'Erratum to: FCGR3A-158 polymorphism influences the biological response to infliximab in Crohn’s disease through affecting the ADCC activity [Immunogenetics, 65, (2013) 265-271, DOI 10.1007/s00251-013-0679-8]', Immunogenetics, vol. 67, no. 9, pp. 545. https://doi.org/10.1007/s00251-015-0861-2

Moroi, Rintaro ; Endo, Katsuya ; Kinouchi, Yoshitaka ; Shiga, Hisashi ; Kakuta, Yoichi ; Kuroha, Masatake ; Kanazawa, Yoshitake ; Shimodaira, Yosuke ; Horiuchi, Takahiko ; Takahashi, Seiichi ; Shimosegawa, Tooru. / Erratum to : FCGR3A-158 polymorphism influences the biological response to infliximab in Crohn’s disease through affecting the ADCC activity [Immunogenetics, 65, (2013) 265-271, DOI 10.1007/s00251-013-0679-8]. In: Immunogenetics. 2015 ; Vol. 67, No. 9. pp. 545.

@article{ba1dabca370b4d70825e61b2305da76b,

title = "Erratum to: FCGR3A-158 polymorphism influences the biological response to infliximab in Crohn{\textquoteright}s disease through affecting the ADCC activity [Immunogenetics, 65, (2013) 265-271, DOI 10.1007/s00251-013-0679-8]",

author = "Rintaro Moroi and Katsuya Endo and Yoshitaka Kinouchi and Hisashi Shiga and Yoichi Kakuta and Masatake Kuroha and Yoshitake Kanazawa and Yosuke Shimodaira and Takahiko Horiuchi and Seiichi Takahashi and Tooru Shimosegawa",

year = "2015",

month = sep,

day = "19",

doi = "10.1007/s00251-015-0861-2",

language = "English",

volume = "67",

pages = "545",

journal = "Immunogenetics",

issn = "0093-7711",

publisher = "Springer Verlag",

number = "9",

}

TY - JOUR

T1 - Erratum to

T2 - FCGR3A-158 polymorphism influences the biological response to infliximab in Crohn’s disease through affecting the ADCC activity [Immunogenetics, 65, (2013) 265-271, DOI 10.1007/s00251-013-0679-8]

AU - Moroi, Rintaro

AU - Endo, Katsuya

AU - Kinouchi, Yoshitaka

AU - Shiga, Hisashi

AU - Kakuta, Yoichi

AU - Kuroha, Masatake

AU - Kanazawa, Yoshitake

AU - Shimodaira, Yosuke

AU - Horiuchi, Takahiko

AU - Takahashi, Seiichi

AU - Shimosegawa, Tooru

PY - 2015/9/19

Y1 - 2015/9/19

UR - http://www.scopus.com/inward/record.url?scp=84939473811&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939473811&partnerID=8YFLogxK

U2 - 10.1007/s00251-015-0861-2

DO - 10.1007/s00251-015-0861-2

M3 - Comment/debate

AN - SCOPUS:84939473811

VL - 67

SP - 545

JO - Immunogenetics

JF - Immunogenetics

SN - 0093-7711

IS - 9

ER -

Erratum to: FCGR3A-158 polymorphism influences the biological response to infliximab in Crohn’s disease through affecting the ADCC activity [Immunogenetics, 65, (2013) 265-271, DOI 10.1007/s00251-013-0679-8]

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this